MODE

Serial Number 98112146
733

Registration Progress

Application Filed
Aug 1, 2023
Under Examination
Dec 26, 2023
Approved for Publication
Oct 31, 2023
Published for Opposition
Oct 31, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 26, 2025 12 days

Trademark Image

MODE

Basic Information

Serial Number
98112146
Filing Date
August 1, 2023
Published for Opposition
October 31, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Dec 10, 2025
Application
Pending
Classes
005 042

Rights Holder

Biohaven Therapeutics Ltd.

99
Address
PO Box 173, Ritter House
Road Town, Tortola VG1110
VG

Ownership History

Biohaven Therapeutics Ltd.

Original Applicant
99
Road Town, Tortola VG

Biohaven Therapeutics Ltd.

Owner at Publication
99
Road Town, Tortola VG

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

Next Deadline
12 days remaining
NOA E-Mailed - SOU Required
Due Date
December 26, 2025
Extension Available
Until June 26, 2026

Application History

28 events
Date Code Type Description Documents
Dec 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 10, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 10, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 24, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 23, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 23, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 23, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 13, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 12, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 3, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 2, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 2, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 26, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 29, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 29, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Nov 29, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 31, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 31, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 11, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 25, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 23, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 30, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 4, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Class 042
Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification

International Classes
005 042